January 17, 2013
A Texas federal judge on Thursday threw out False Claims Act allegations against a Johnson & Johnson unit and Boston Scientific Corp., but said an employee whistleblower suit alleging Abbott Laboratories marketed stents off-label should continue.
October 23, 2012
Boston Scientific Corp., Abbott Laboratories and a Johnson & Johnson unit on Monday urged a Texas federal judge to end a former Guidant Corp. employee's long-running whistleblower litigation over off-label marketing of digestive tract stents, arguing he still hasn't sufficiently alleged False Claims Act violations.
April 09, 2012
A former Guidant Corp. employee asked a Texas federal court Friday to reopen a qui tam suit alleging Boston Scientific Corp., Abbott Laboratories and other makers of digestive tract stents entered a marketing scheme to promote the products for unapproved uses elsewhere in the body.